The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases

Journal of Rheumatology

Volumn 38, Issue 2, 2011, Pages 191-194

  Sanderson, Tessa C ^a   Hewlett, Sarah E ^a   Flurey, Caroline ^a   Dures, Emma ^a   Richards, Pamela ^b   Kirwan, John R ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPING BEHAVIOR; DISABILITY; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; FATIGUE; HUMAN; MEASUREMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; RHEUMATIC DISEASE; SELF CARE; SELF REPORT; SYMPTOM;

COST OF ILLNESS; HUMANS; QUALITY OF LIFE; RHEUMATIC DISEASES; SELF CARE; SEVERITY OF ILLNESS INDEX;

EID: 79551715973     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100700     Document Type: Editorial

References (20)

1. Kalyoncu U, Dougados M, Daures J, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2009;68:183-90.
2. Food and Drug Administration. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labelling claims. 18 December 2009, UCM 193282. [Internet. Accessed September 27, 2010.] Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
3. Hewlett S. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877-9.
4. Hewlett S, Sanderson T, May J, O'Bingham C, March L, Alten R, et al. "Just shoot me": RA patients experience flare as more than painful, swollen joints [abstract]. Rheumatology 2010;49 Suppl 1:i141.
5. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the Rheumatoid Arthritis Patient Priorities for Pharmacological Interventions (RAPP-PI) outcomes. Arthritis Care Res 2010;62:647-56.
6. Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in RA: A cross sectional study to evaluate the Bristol RA Fatigue Multi-Dimensional Questionnaire, Visual Analogue and Numerical Rating Scales (BRAF). Arthritis Care Res 2010 Jun 25. Epub ahead of print
7. Gately C, Rogers A, Sanders C. Re-thinking the relationship between long-term condition self-management education and the utilisation of health services. Soc Sci Med 2007;65:934-45.
8. Department of Health. National service framework for long-term conditions. London: Department of Health; 2005.
9. Kralik D, Koch T, Price K, Howard N. Patient involvement in clinical nursing, J Clin Nurs 2004;13:259-67.
10. van der Heijde D, Hof M, Piet L, Putte L. Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
11. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. The elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: A EULAR initiative. Ann Rheum Dis 2009;36:2097-9.
12. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire: An individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987;14:446-51.
13. O'Boyle CA, McGee H, Hickey A, Joyce CRB, Browne J, O'Malley K, et al. The schedule for evaluation of individual quality of life. User manual. Dublin: Department of Psychology, Royal College of Surgeons in Ireland; 1993.
14. Hewlett S, Smith AP, Kirwan JR. Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ). Ann Rheum Dis 2002;61:986-93.
15. Verhoeven AC, Boers M, van der Liden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000;27:2801-9.
16. Seror R, Tubach F, Baron G, Guillemin F, Ravaud P. Measure of function in rheumatoid arthritis: individualised or classical scales? Ann Rheum Dis 2010;69:97-101.
17. ten Klooster PM, Taal E, Veehof MM, vand de Laar AFJ. Changes in priorities for health status improvement in patients with rheumatoid arthritis after TNF-blocking treatment [abstract]. Arthritis Rheum 2006;54 Suppl:S768.
18. Hewlett S, Cockshott Z, Kirwan J, Barrett J, Stamp J, Haslock I. Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE). Rheumatology 2001;40:1221-30.
19. Ahmed S, Mayo NE, Wood-Dauphinee S, Hanley JA, Cohen SR. Response shift influenced estimates of change in health-related quality of life poststroke. J Clin Epidemiol 2004;57:561-70.
20. Ring L, Hofer S, Heuston F, Harris D, O'Boyle CA. Response shift masks the treatment impact on patient reported outcomes (PROs): The example of individual quality of life in edentulous patients. Health Qual Life Outcomes 2005;3:55.